Form 4 for CYAB CYABRA, INC.

Accepted 2026-07-13 17:09:20 ET · period of report 2026-07-10 · accession 0001213900-26-077644 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-07-13 17:09	2026-07-10	CYAB	Flanagan James Francis	Dir	A - Grant	$0.435	+114.9K	224.9K	+104%	+$50.0K
DM	2026-07-13 17:09	2026-07-10	CYAB	Flanagan James Francis	Dir	P - Purchase	$0.475	+229.9K	229.9K	New	+$109.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-07-10	A	A	114,940	$0.435	224,940	D	—	—	(F1) On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.
2	Derivative	Common Stock Warrants (right to buy)	2026-07-10	P	A	114,940	$0.45	114,940	D	$0.45 · — to —	114,940 Common Stock	(F2) The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. (F3) The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. (F4) The Series B Warrants expire twelve (12) months following the initial exercise date.
3	Derivative	Common Stock Warrants (right to buy)	2026-07-10	P	A	114,940	$0.5	229,880	D	$0.5 · — to —	114,940 Common Stock	(F5) The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. (F6) The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. (F7) The Series A Warrants expire five (5) years following the initial exercise date.